First Trust Advisors’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-30,564
| Closed | -$624K | – | 2550 |
|
|
2021
Q1 | $624K | Buy |
+30,564
| New | +$624K | ﹤0.01% | 2144 |
|
|
2020
Q4 | – | Sell |
-43,608
| Closed | -$645K | – | 2410 |
|
|
2020
Q3 | $645K | Sell |
43,608
-33,977
| -44% | -$503K | ﹤0.01% | 1939 |
|
|
2020
Q2 | $1.63M | Sell |
77,585
-11,831
| -13% | -$248K | ﹤0.01% | 1486 |
|
|
2020
Q1 | $2.07M | Buy |
89,416
+38,724
| +76% | +$895K | ﹤0.01% | 1256 |
|
|
2019
Q4 | $1.31M | Buy |
+50,692
| New | +$1.31M | ﹤0.01% | 1771 |
|
|
2019
Q2 | – | Sell |
-83,039
| Closed | -$1.88M | – | 2498 |
|
|
2019
Q1 | $1.88M | Sell |
83,039
-4,594
| -5% | -$104K | ﹤0.01% | 1581 |
|
|
2018
Q4 | $2.24M | Buy |
+87,633
| New | +$2.24M | 0.01% | 1407 |
|
|
2017
Q4 | – | Sell |
-21,118
| Closed | -$723K | – | 2458 |
|
|
2017
Q3 | $723K | Buy |
21,118
+8,700
| +70% | +$298K | ﹤0.01% | 1961 |
|
|
2017
Q2 | $495K | Sell |
12,418
-2,880
| -19% | -$115K | ﹤0.01% | 2064 |
|
|
2017
Q1 | $563K | Sell |
15,298
-24,457
| -62% | -$900K | ﹤0.01% | 2041 |
|
|
2016
Q4 | $1.27M | Buy |
+39,755
| New | +$1.27M | ﹤0.01% | 1721 |
|